Adiposs news
Adiposs SA, a Geneva-based biotech company developing medical imaging products, has successfully launched its phase 1 clinical trial on August 10, with the dosing of the first human subjects with ImageBATTM, its first-in-class product for brown fat imaging.
Adiposs has initiated the clinical development of its flagship imaging product, ImageBATTM. The primary objective of the IBT001 phase 1 clinical trial is to evaluate the safe
GENEVA, SWITZERLAND – DECEMBER 24, 2021 – Adiposs SA, the developer of a unique diagnostic product for the non-invasive early detection of body wasting-cachexia, announced a CHF 1.8M first closing of its Pre-Series A round. The round was led by Privilège Ventu
- Private pitching and feedback sessions with top Life Sciences investors;
- Public pitching and networking events with investors and industry leaders from the Boston area;
We are thrilled to announce that following the scientific advice meeting with The Medicines and Healthcare products Regulatory Agency in the UK, Adiposs received endorsement for its flagship product, ImageBAT, to proceed to Clinical Trials.
ImageBAT is the state-of-the-art imaging product that makes brown adipose tissue visible with a fast and pain-f